Associations between HbA1c Glycation Index and Risk of Chronic Complications of Diabetes Mellitus
1.School of Nursing,Nanjing Medical University,Nanjing 211166,China
2.The First Affiliated Hospital with Nanjing Medical University,Nanjing 210029,China
3.Gulou District Mofan West Road Community Health Center,Nanjing 210013,China
4.Shanghai Cancer Institute,Shanghai 200032,China
5.Jiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,China
6.Nanjing Brain Hospital Affiliated to Nanjing Medical University,Nanjing 210029,China
*Corresponding author:WANG Jie,Associate professor,Master supervisor;E-mail:wangjienjmu@126.com
ZHONG Yuling,FAN Haozhi,ZHANG Ru, et al. Associations between HbA1c Glycation Index and Risk of Chronic Complications of Diabetes Mellitus [J]. Chinese General Practice, 2020, 23(3): 276-280. DOI: 10.12114/j.issn.1007-9572.2019.00.523.
钟玉玲,凡豪志,张茹等. 糖化血红蛋白变异指数与糖尿病慢性并发症发生风险的相关性研究[J]. 中国全科医学, 2020, 23(3): 276-280. DOI: 10.12114/j.issn.1007-9572.2019.00.523.
[1]International Diabetes Ferderation(IDF).IDF Diabetes Atlas (Eighth edition 2017)[EB/OL].[2019-01-20].http://www.diabetesatlas.org.
[2]NCD Risk Factor Collaboration (NCD-RISC).Worldwide trends in diabetes since 1980:a pooled analysis of 751 population-based studies with 4.4 million participants[J].Lancet,2016,387(10027):1513-1530.DOI:10.1016/S0140-6736(16)00618-8.
[3]CHAMBERLAIN J J,RHINEHART A S,SHAEFER C F Jr,et al.Diagnosis and management of diabetes:synopsis of the 2016 American diabetes association standards of medical care in diabetes[J].Ann Intern Med,2016,164(8):542.DOI:10.7326/m15-3016.
[4]GILLETT M J.International expert committee report on the role of the A1c assay in the diagnosis of diabetes:diabetes care 2009;32(7):1327-1334[J].Clin Biochem Rev,2009,30(4):197-200.
[5]NATHAN D M,TURGEON H,REGAN S.Relationship between glycated haemoglobin levels and mean glucose levels over time[J].Diabetologia,2007,50(11):2239-2244.DOI:10.1007/s00125-007-0803-0.
[6]MARINI M A,FIORENTINO T V,SUCCURRO E,et al.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals[J].PLoS One,2017,12(4):e0175547.DOI:10.1371/journal.pone.0175547.
[7]HERMAN W H,MA Y,UWAIFO G,et al.Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program[J].Diabetes Care,2007,30(10):2453-2457.DOI:10.2337/dc06-2003.
[8]SOROS A A,CHALEW S A,MCCARTER R J,et al.Hemoglobin glycation index:a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients[J].Pediatr Diabetes,2010,11(7):455-461.DOI:10.1111/j.1399-5448.2009.00630.x.
[9]HEMPE J M,GOMEZ R,MCCARTER R J Jr,et al.High and low hemoglobin glycation phenotypes in type 1 diabetes:a challenge for interpretation of glycemic control[J].J Diabetes Complicat,2002,16(5):313-320.
[10]HEMPE J M,LIU S Q,MYERS L,et al.The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial[J].Diabetes Care,2015,38(6):1067-1074.DOI:10.2337/dc14-1844.
[11]GENUTH S,LACHIN J M,NATHAN D M.Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes:response to McCarter et al[J].Diabetes Care,2005,28(1):233;author reply 234-233;author reply 234-5.DOI:10.2337/diacare.28.1.233.
[12]WHO.Definition,Diagnosis,and Classification of Diabetes.Diagnosis & Classification of Diabetes Mellitus 1999[EB/OL].
[2019-01-20].https://www.staff.ncl.ac.uk/philip.home/who_dmc.htm.
[13]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志:电子版,2011,3(6):54-109.DOI:10.3969/j.issn.1674-7372.2011.06.014.
[14]American Diabetes Association.11.microvascular complications and foot care:standards of medical care in diabetes-2019[J].Diabetes Care,2019,42(Suppl 1):S124-138.DOI:10.2337/dc19-S011.
[15]AHN J H,YU J H,KO S H,et al.Prevalence and determinants of diabetic nephropathy in Korea:Korea national health and nutrition examination survey[J].Diabetes Metab J,2014,38(2):109-119.DOI:10.4093/dmj.2014.38.2.109.
[16]TUTTLE K R,BAKRIS G L,BILOUS R W,et al.Diabetic kidney disease:a report from an Ada consensus conference[J].Diabetes Care,2014,37(10):2864-2883.DOI:10.2337/dc14-1296.
[17]KILPATRICK E S,RIGBY A S,ATKIN S L.A1C variability and the risk of microvascular complications in type 1 diabetes:data from the Diabetes Control and Complications Trial[J].Diabetes Care,2008,31(11):2198-2202.DOI:10.2337/dc08-0864.
[18]WADéN J,FORSBLOM C,THORN L M,et al.A1C variability predicts incident cardiovascular events,microalbuminuria,and overt diabetic nephropathy in patients with type 1 diabetes[J].Diabetes,2009,58(11):2649-2655.DOI:10.2337/db09-0693.
[19]HEMPE J M,GOMEZ R,MCCARTER R J Jr,et al.High and low hemoglobin glycation phenotypes in type 1 diabetes:a challenge for interpretation of glycemic control[J].J Diabetes Complicat,2002,16(5):313-320.
[20]RODRíGUEZ-SEGADE S,RODRíGUEZ J,CABEZAS-AGRICOLA J M,et al.Progression of nephropathy in type 2 diabetes:the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)[J].Clin Chem,2011,57(2):264-271.DOI:10.1373/clinchem.2010.144949.
[21]KOVATCHEV B,COBELLI C.Glucose variability:timing,risk analysis,and relationship to hypoglycemia in diabetes[J].Diabetes Care,2016,39(4):502-510.DOI:10.2337/dc15-2035.
[22]CERIELLO A,COLAGIURI S.International diabetes federation guideline for management of postmeal glucose:a review of recommendations[J].Diabet Med,2008,25(10):1151-1156.DOI:10.1111/j.1464-5491.2008.02565.x.
[23]ZHAO Q,ZHOU F,ZHANG Y S,et al.Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes:a systematic review and meta-analysis[J].Diabetes Res Clin Pract,2019,148:23-31.DOI:10.1016/j.diabres.2018.12.010.
[24]KIM M K,JEONG J S,YUN J S,et al.Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus:a 10-year longitudinal cohort study[J].J Diabetes Complicat,2018,32(10):906-910.DOI:10.1016/j.jdiacomp.2018.08.007.
[25]CHENG P C,HSU S R,CHENG Y C,et al.Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus:a cross-sectional study[J].Peer J,2017,5:e3875.DOI:10.7717/peerj.3875.
[26]FIORENTINO T V,MARINI M A,SUCCURRO E,et al.Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction[J].Oncotarget,2017,8(45):79576-79586.DOI:10.18632/oncotarget.18572.
[27]KOSKA J,SAREMI A,HOWELL S,et al.Advanced glycation end products,oxidation products,and incident cardiovascular events in patients with type 2 diabetes[J].Diabetes Care,2018,41(3):570-576.DOI:10.2337/dc17-1740.
[28]RABBANI N,THORNALLEY P J.Advanced glycation end products in the pathogenesis of chronic kidney disease[J].Kidney Int,2018,93(4):803-813.DOI:10.1016/j.kint.2017.11.034.
[29]HOFMANN B,ADAM A C,JACOBS K,et al.Advanced glycation end product associated skin autofluorescence:a mirror of vascular function?[J].Exp Gerontol,2013,48(1):38-44.DOI:10.1016/j.exger.2012.04.011.
[11]BORLAUG B A,KANE G C,MELENOVSKY V,et al.Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction[J].Eur Heart J,2016,37(43):3293-3302.DOI:10.1093/eurheartj/ehw241.
[12]VAN HEEREBEEK L,PAULUS W J.Understanding heart failure with preserved ejection fraction:where are we today?[J].Neth Heart J,2016,24(4):227-236.DOI:10.1007/s12471-016-0810-1.
[13]THOMPSON R B,PAGANO J J,CHOW K,et al.Subclinical pulmonary edema is associated with reduced exercise capacity in HFpEF and HFrEF[J].J Am Coll Cardiol,2017,70(14):1827-1828.DOI:10.1016/j.jacc.2017.07.787.
[14]梁峰,胡大一,方全,等.左室射血分数保留的心力衰竭[J].中国循证心血管医学杂志,2015,7(5):706-709.DOI:10.3969/j.issn.1674-4055.2015.05.42.
[15]寇威,薛永亮,刘晓琰,等.左室射血分数保留心力衰竭患者加用螺内酯治疗一例[J].中国实用医刊,2017,44(14):125-126.DOI:10.3760/cma.j.issn.1674-4756.2017.14.041.
[16]TROMP J,KHAN M A,KLIP I T,et al.Biomarker profiles in heart failure patients with preserved and reduced ejection fraction[J].J Am Heart Assoc,2017,6(4):e003989.DOI:10.1161/JAHA.116.003989.
[17]PITT B,PFEFFER M A,ASSMANN S F,et al.Spironolactone for heart failure with preserved ejection fraction[J].N Engl J Med,2014,370(15):1383-1392.DOI:10.1056/NEJMoa1313731.
[18]秦榕蔚,陈茉,黄花.射血分数保留心力衰竭患者血清半乳糖凝集素-3水平变化及意义[J].中国循证心血管医学杂志,2018,10(8):957-960.DOI:10.3969/j.issn.1674-4055.2018.08.17.
QIN R W,CHEN M,HUANG H.Changes and significance of serum galectin-3 level in patients with heart failure with preserved ejection fraction[J].Chinese Journal of Evidence-Bases Cardiovascular Medicine,2018,10(8):957-960.DOI:10.3969/j.issn.1674-4055.2018.08.17.
[19]李丹,童嘉毅.射血分数保留心衰相关肺高压及其危险因素[J].现代医学,2017,45(6):890-894.
[20]石衍梅,尉若川,李虹.左室射血分数保留心衰的研究进展[J].中西医结合心脑血管病杂志,2016,14(15):1744-1746.DOI:10.3969/j.issn.1672-1349.2016.15.015.